StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mallinckrodt (MNK) Weakness Tied to FDA Panel Review
May 3, 2018 2:36 PM
Mallinckrodt (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
Mallinckrodt (MNK) Seen as Target of Negative Upcoming 60 Minutes Episode
May 4, 2018 10:06 AM
Mallinckrodt (MNK) Reports Negative FDA Advisory Committee Vote on Stannsoporfin for Treatment of Newborns at Risk of Developing Severe Jaundice
May 4, 2018 6:21 AM
Mallinckrodt (MNK) Active, Shares Decline
May 3, 2018 2:32 PM
